|
| |
Image Results
Loading...
Loading...
Collateral Therapeutics Incorporated Pages on BioPortfolio:
BioPortfolio - Biocorporate Search Muscle1
Collateral Therapeutics Incorporated. Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance ...
http://www.bioportfolio.com/biocorporate/Muscle-companies.ht...
|
NASDAQ Biotechnology Companies - Barr - Dynacare
CIPH · CIPHERGEN BIOSYSTEMS INC, Nasdaq, Biotech. CBZ, COBALT CORP, NYSE, Services to Med Profs. CLTX · COLLATERAL THERAPEUTICS INC, Nasdaq, Biotech ...
http://www.bioportfolio.com/nasdaq/nasdaq_barr_dynacare.htm...
|
BioPortfolio News: Alexandria Real Estate Equities, Inc ...
Pfizer Inc. recently completed a sublease with Nektar Therapeutics, which will use this ... The collateral for this loan consists of six properties, ...
http://www.bioportfolio.com/news/Alexandria-Real-Estate-Equi...
|
|
BioPortfolio - Cardium Therapeutics - Cardium Reports on ...
Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, ... treatment to promote and stimulate the growth of collateral circulation in the
...
http://www.bioportfolio.com/news/Cardium_Reports_on_Applicab...
|
BioPortfolio - Alexandria Real Estate Equities, Inc. - Alexandria ...
Therapeutics, Inc., Ion Torrent Systems, Inc., the J. David Gladstone Institutes , UCSF Orthopedic Clinic ... The collateral for this loan consists of six ...
http://www.bioportfolio.com/news/Alexandria-Real-Estate-Equi...
|
BioPortfolio - Accentia BioPharmaceuticals - Profile
specialty pharmaceuticals and biologics for targeted therapeutics. ... BioPharmaceuticals, Inc (Nasdaq:ABPI) is a vertically-integrated specialty ...
undesirable collateral damage (i.e. toxicity), while boosting efficacy. ...
http://www.bioportfolio.com/biocorporate/30827-Accentia+BioP...
|
BioPortfolio - Brain
Collateral neuronal apoptosis in CNS gray matter during an ... Acorda Therapeutics, Inc. was established in March 1995 to develop therapeutic products
for ...
http://www.bioportfolio.com/indepth/Brain.html...
|
BioPortfolio - Ligaments
29 Sep 2009 ... BioMimetic Therapeutics, Inc. is an emerging leader in the development and commercialization of drug-device combination products for the ...
http://www.bioportfolio.com/indepth/Ligaments.html...
|
BioPortfolio - Global Health Economics & Outcomes Research - Profile
'Wellbeing': A collateral casualty of modernity? In the now vast empirical and theoretical ... Orexigen Therapeutics,. Inc. -- There was no evidence of ...
http://www.bioportfolio.com/biocorporate/23579-Global+Health...
|
BioPortfolio - Sleep Apnea
Occurence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion ... Therapeutics Daily: Oct 29 2009 3:23PM Matching: sleep
apnea ... Hypnion Incorporated. Hypnion, Inc. is a recently founded, ...
http://www.bioportfolio.com/indepth/Sleep_Apnea.html...
| Results from other life science and pharmaceutical sites:
BioSpace - Collateral Therapeutics Inc. News, Search Jobs, Events
Collateral Therapeutics Inc. 11622 El Camino Real San Diego California 92130 U.S.A.. Phone: 858-794-3400 Fax: 858-794-3444 ...
http://www.biospace.com/company_profile.aspx?CompanyId=3386...
|
Collateral Therapeutics, Inc. Company Profile - Yahoo! Finance
No collateral damage here. Collateral Therapeutics, a subsidiary of Schering AG, develops gene therapies to treat various cardiovascular diseases as an ...
http://biz.yahoo.com/ic/56/56944.html...
|
Controlled expression of cardiac-directed adenylylcyclase type VI ...
Collateral Therapeutics Incorporated, San Diego, CA, USA. OBJECTIVE: We have previously shown that cardiac-directed expression of adenylycyclase type VI ...
http://www.ncbi.nlm.nih.gov/pubmed/12393090...
|
Halozyme Therapeutics - Board of Directors
His research and clinical work led to the founding of two successful biotechnology companies: Gensia, Inc., and Collateral Therapeutics, Inc. He also
...
http://www.halozyme.com/aboutus_board_of_directors.php...
|
Angiogenic gene therapy strategies for the treatment of ...
GenVec Inc, Gaithersburg, MD 20878, USA. hrasmussen@genvec.com ... Ad5-FGF4 ( Collateral Therapeutics Inc/Schering Inc) and NV1FGF (Aventis Pharma AG/Aventis
...
http://www.ncbi.nlm.nih.gov/pubmed/12435049...
|
Increased expression of adenylylcyclase type VI proportionately ...
Portions of this research were supported by an unrestricted grant from Collateral Therapeutics, Inc., La Jolla, CA; H.K.H. has a proprietary interest
in ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
Alferminogene tadenovec, an angiogenic FGF4 gene therapy for ...
Following early clinical development by Collateral Therapeutics Inc (now Bayer Schering Pharma AG), Cardium Therapeutics Inc is currently developing ...
http://www.ncbi.nlm.nih.gov/pubmed/18379964...
|
Molecular Therapy - Abstract of article: Absence of Germline ...
1Department of Genetics, University of Washington, Seattle, Washington, 98195, USA; 2Collateral Therapeutics, Inc., San Diego, California, 92130, USA ...
http://www.nature.com/mt/journal/v4/n6/abs/mt2001278a.html...
|
Intracoronary delivery of an adenovirus encoding fibroblast growth ...
Collateral Therapeutics Inc., San Diego, CA 92130, USA. droth@genetherapysystems .com. The presence of anti-adenoviral serotype 5 (Ad5) antibodies may limit ...
http://www.ncbi.nlm.nih.gov/pubmed/16454656...
|
Phenylephrine protects neonatal rat cardiomyocytes from hypoxia ...
Correspondence to: H Zhu, Collateral Therapeutics, Inc. Research Center, Suite 100, 11025 Roselle Street, San Diego, CA 92121, USA. Fax: (858) 404-9350; ...
http://www.nature.com/cdd/journal/v7/n9/abs/4400721a.html...
|
|
